FDA Warning Letter — Maxlife

Case 721453 — FEI 3042458079

The FDA took a Warning Letter action against Maxlife on Feb 20, 2026 (Tempe, AZ). The action was issued by CDER and concerns drugs products.

Action details

Facility
Maxlife
Date
Feb 20, 2026
Fiscal Year
2026
Product Type
Drugs
Center
CDER
Location
Tempe, AZ (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.